Auto- versus human-driven plan in mediastinal Hodgkin lymphoma radiation treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Auto- versus human-driven plan in mediastinal Hodgkin lymphoma radiation treatment ; volume:13 ; number:1 ; day:19 ; month:10 ; year:2018 ; pages:1-10 ; date:12.2018
Radiation oncology ; 13, Heft 1 (19.10.2018), 1-10, 12.2018
- Creator
-
Clemente, Stefania
- Contributor
-
Oliviero, Caterina
Palma, Giuseppe
D’Avino, Vittoria
Liuzzi, Raffaele
Conson, Manuel
Pacelli, Roberto
Cella, Laura
SpringerLink (Online service)
- DOI
-
10.1186/s13014-018-1146-3
- URN
-
urn:nbn:de:101:1-2018112622145482024421
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Clemente, Stefania
- Oliviero, Caterina
- Palma, Giuseppe
- D’Avino, Vittoria
- Liuzzi, Raffaele
- Conson, Manuel
- Pacelli, Roberto
- Cella, Laura
- SpringerLink (Online service)
Other Objects (12)
Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
Hodgkin lymphoma: hypodense lesions in mediastinal masses
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
Pulmonary fibrosis occurring as a sequel to mediastinal irradiation in hodgkin′s lymphoma
Dosimetric advantages of a “butterfly” technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin’s lymphoma
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma
Cutaneous Hodgkin’s lymphoma
Ultraviolet radiation exposure and HIV-associated non-Hodgkin lymphoma risk
Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma
Radiotherapy for Hodgkin lymphoma
Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
Hodgkin lymphoma: hypodense lesions in mediastinal masses
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
Pulmonary fibrosis occurring as a sequel to mediastinal irradiation in hodgkin′s lymphoma
Dosimetric advantages of a “butterfly” technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin’s lymphoma
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma
Cutaneous Hodgkin’s lymphoma
Ultraviolet radiation exposure and HIV-associated non-Hodgkin lymphoma risk
Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma
Radiotherapy for Hodgkin lymphoma
Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
Hodgkin lymphoma: hypodense lesions in mediastinal masses
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
Pulmonary fibrosis occurring as a sequel to mediastinal irradiation in hodgkin′s lymphoma
Dosimetric advantages of a “butterfly” technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin’s lymphoma
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma
Cutaneous Hodgkin’s lymphoma
Ultraviolet radiation exposure and HIV-associated non-Hodgkin lymphoma risk
Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma